Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Natera, Inc. - Common Stock
(NQ:
NTRA
)
138.71
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Natera, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Supreme Court Denies CareDx Request for Appeal in Patent Case with Natera
October 03, 2023
From
Natera, Inc.
Via
Business Wire
Natera Submits First PMA Module to the FDA for Signatera™
October 02, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces Senior Leadership Appointments
September 18, 2023
From
Natera, Inc.
Via
Business Wire
The Latest Analyst Ratings for Natera
August 08, 2023
Via
Benzinga
Why Natera Stock Is Soaring Today
August 04, 2023
This DNA testing leader passed the test in Q2.
Via
The Motley Fool
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Natera Earnings Preview
August 02, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via
Benzinga
Natera Announces Expanded I-SPY 2 Collaboration to Evaluate Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting
September 14, 2023
From
Natera, Inc.
Via
Business Wire
What 7 Analyst Ratings Have To Say About Natera
July 21, 2023
Via
Benzinga
Analyst Expectations for Natera's Future
May 30, 2023
Via
Benzinga
Natera Announces Pricing of $250 Million Follow-On Offering
September 07, 2023
From
Natera, Inc.
Via
Business Wire
Natera Launches Proposed Follow-On Offering
September 06, 2023
From
Natera, Inc.
Via
Business Wire
Natera to Participate in Upcoming Investor Conferences
September 01, 2023
From
Natera, Inc.
Via
Business Wire
Natera’s Prospera™ Lung Transplant Assessment Test Granted Medicare Coverage
August 16, 2023
From
Natera, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
August 04, 2023
Via
Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 04, 2023
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Via
Benzinga
Investors Cheer Jobs Report: Why Are These 5 Stocks And 5 ETFs Shining On Friday?
August 04, 2023
Via
Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
August 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 03, 2023
Via
Benzinga
Natera Reports Second Quarter 2023 Financial Results
August 03, 2023
From
Natera, Inc.
Via
Business Wire
Natera to Participate in Canaccord Genuity 43rd Annual Growth Conference
August 02, 2023
From
Natera, Inc.
Via
Business Wire
Natera Files Patent Infringement Suit Against NeoGenomics
July 31, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera™ in Colorectal Cancer
July 28, 2023
From
Natera, Inc.
Via
Business Wire
Natera to Report its Second Quarter 2023 Results on August 3rd
July 27, 2023
From
Natera, Inc.
Via
Business Wire
Court Issues Favorable Ruling for Natera in False Advertising Trial Against CareDx; Eliminates all Damages
July 17, 2023
From
Natera, Inc.
Via
Business Wire
Natera to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
June 06, 2023
From
Natera, Inc.
Via
Business Wire
Natera Announces Data from the ProActive Study that Supports Prospera™ Kidney as an Early Indicator of Transplant Rejection
June 04, 2023
From
Natera, Inc.
Via
Business Wire
New Natera Data to be Presented at the 2023 ASCO Annual Meeting in 13 Studies Across Multiple Cancer Types
May 30, 2023
From
Natera, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.